Section: 
School of pharmacotherapy
School of pharmacotherapyExperience in the use of the drug „Aqua Maris Strong for Throat“in the complex treatment of inflammatory diseases of the larynx
B. B. Uraskulovа (1), A. O. Gyusan (1)
(1) Medical Institute of the North Caucasus State Academy, Cherkessk, 369000, Russia
UDK: УДК 616.22-002.1/2.-008.87-078-08-035
DOI: https://doi.org/10.18692/1810-4800-2022-3-148-154
ABSTRACT
Currently, the treatment of patients with inflammatory diseases of the larynx in most cases is multi-stage, long-term, and requires numerous techniques using specialized equipment. In the daily work of an otorhinolaryngologist with inflammatory diseases of the larynx, drugs are most often used in the form of injections or oral use. Aerosol therapy enables fast and effective therapeutic action with the use of a relatively small dose of the drug and a significant reduction in the negative systemic effect. An effective means of treating diseases of the upper respiratory tract is irrigation and inhalation therapy using sea water, which moisturizes dry mucous membranes, promotes rapid softening and removal of crusts. To establish the therapeutic efficacy of the use of Aqua Maris Strong for Throat in the complex treatment of inflammatory diseases of the larynx, 76 patients suffering from inflammatory diseases of the larynx were selected, who were divided into the main and control groups of the study. Patients of the main group as part of complex therapy for inflammatory diseases of the larynx received inhalation administration of the drug "Aqua Maris Strong for Throat ". The inhalation procedure consisted of 2 inhalations lasting 10 minutes, 2 times a day. The control group of patients – 37 patients received traditional etiotropic treatment of inflammatory diseases of the larynx. As the study showed, in patients who received inhalation administration of the Aqua Maris Strong for Throat preparation as part of the complex therapy of inflammatory diseases of the larynx, positive dynamics of complaints, normalization of the laryngostroboscopic picture were noted faster than in patients of the control group. The advantage of therapy using Aqua Maris Strong for Throat was also confirmed by the restoration of cytopathological changes in local cellular protection, in the form of a decrease in signs of deepithelialization, mucociliary insufficiency, phagocytosis of cellular elements, a decrease in the concentration of pathological flora on the laryngeal mucosa in a shorter period of time than in patients in the control group.
Publication date:
27.06.2022
Keywords:
laryngitis, Aqua Maris Strong for Throat, inhalations. For citation:
Uraskulova B. B., Gyusan A. O. Experience in the use of the drug „Aqua Maris Strong for Throat“in the complex treatment of inflammatory diseases of the larynx. Rossiiskaya otorinolaringologiya. 2022;21(3):148-154. https://doi.org/10.18692/1810-4800-2022-3-148-154